FLUence project

Dear colleague, the purpose of this survey is to understand your opinion about influenza vaccination in adult patients, with a focus on people living with cardiovascular diseases. This survey is voluntary, and all of your responses, as well as your participation in the survey itself, will be anonymized. Participating in this project will take less than 4 minutes, and your contribution will greatly assist us.
By answering the survey, you are providing your consent to be part of this project.

Thank you very much for your help!

Question Title

* Country

Question Title

* Age

Question Title

* Sex

Question Title

* Specialty

Question Title

* Are you currently in training?

Question Title

* How long have you been practicing in your specialization (in years)?

Question Title

* Health Care Setting where you work

Question Title

* Have you been vaccinated against influenza in the last 12 months?

Question Title

* Do you know if the influenza vaccine is available in your country?

Question Title

* Do you know if the influenza vaccine is covered by social insurance, government or any other health insurance in your country?

Question Title

* Do you know if high risk cardiovascular patients get the influenza vaccine free of charge in your country?

Question Title

* In your country, what providers are responsible for prescribing influenza vaccination? (Select all that apply)

Question Title

* Have you ever prescribed the influenza vaccine to any patient?

Question Title

* Do you know if there is an age in your country after which all adults should be vaccinated, regardless of their comorbidities?

Question Title

* Do you know if the influenza vaccine is considered an essential medicine in your country?

Question Title

* Do you know of any general or specific guidelines that make recommendations about influenza vaccination in patients with cardiovascular disease?

Question Title

* In your country, do you know whether there are different types of influenza vaccine for adults, according to their age or comorbidities?

Question Title

* On a scale from 1 to 5, how safe do you believe the influenza vaccine is in the adult general population? (1 being the most dangerous and 5 the most safer one)

1 5
Clear
i We adjusted the number you entered based on the slider’s scale.

Question Title

* On a scale from 1 to 5, how safe do you believe the influenza vaccine is in patients under antiplatelet or anticoagulation treatment? (1 being the most dangerous and 5 the most safer one)

1 5
Clear
i We adjusted the number you entered based on the slider’s scale.

Question Title

* On a scale from 1 to 5, how serious would it be if your high risk cardiovascular patients  contract influenza? (1 being not very serious and 5 the most serious disease)

1 5
Clear
i We adjusted the number you entered based on the slider’s scale.

Question Title

* If a patient has an acute coronary syndrome, how much time do you think should elapse before safely prescribing the influenza vaccine?

Question Title

* In a patient with heart failure that has been hospitalized, how much time do you think should elapse since hospitalization to safely prescribe the influenza vaccine?

Question Title

* On a scale from 1 to 5, how often do you think adverse effects of any kind occur after influenza vaccination? (1 being very infrequently and 5 very frequent)

1 5
Clear
i We adjusted the number you entered based on the slider’s scale.

Question Title

* On a scale from 1 to 5, how often do you think serious adverse events occur after influenza vaccination?? (1 being very infrequently and 5 very frequent)

Note: serious adverse events as defined by WHO: It causes the death of the vaccinated individual; or It puts the life of the vaccinated individual in imminent danger; or leads to hospitalization or prolongation of hospital stay; or causes persistent or significant disability or incapacity.

1 5
Clear
i We adjusted the number you entered based on the slider’s scale.

Question Title

* On a scale from 1 to 5, how important do you believe the influenza vaccine is for patients aged 65 years and above irrespective of any pre-existing comorbidities?
(1 being the least important intervention and 5 the most important intervention)

1 5
Clear
i We adjusted the number you entered based on the slider’s scale.

Question Title

* On a scale from 1 to 5, how important do you believe the influenza vaccine is for older patients with cardiovascular disease aged 65 years and above? (especially acute or chronic coronary syndrome or heart failure)?
(1 being the least important intervention and 5 the most important intervention)

1 5
Clear
i We adjusted the number you entered based on the slider’s scale.

Question Title

* On a scale from 1 to 5, how important do you believe the influenza vaccine is for younger patients with cardiovascular disease aged below 65 years old? (especially acute or chronic coronary syndrome or heart failure)?
(1 being the least important intervention and 5 the most important intervention)

1 5
Clear
i We adjusted the number you entered based on the slider’s scale.

Question Title

* How likely do you think that the influenza vaccine could provide some benefit to a patient with high cardiovascular risk?
(Put an X where you consider the most suitable probability of benefit or not)

  No benefit Little benefit Great benefit  Not sure
Prevent getting the flu
Reduce myocardial infarction risk
Reduce stroke risk
Reduce mortality risk
Reduce hospitalization for any reason

Question Title

* On a scale of 1 to 5, how comfortable are you with talking to patients about the influenza vaccine risk and benefits?
(1 being not comfortable at all and 5 being very comfortable)

1 5
Clear
i We adjusted the number you entered based on the slider’s scale.

Question Title

* On a scale of 1 to 5, do you feel you need training to discuss the risks and benefits of the influenza vaccine with patients?
(1 being “I don’t need training” and 5 “I definitely need training”)

1 5
Clear
i We adjusted the number you entered based on the slider’s scale.

Question Title

* On a scale from 1 to 5, how important do you think it is to receive information about influenza vaccination for your daily practice?
(1 being the "not at all useful" and 5 being "extremely useful")

1 5
Clear
i We adjusted the number you entered based on the slider’s scale.

Question Title

* What tools/job aids do you need to effectively increase influenza vaccine discussion among your patients? Select all that apply

Question Title

* In your country, do you believe that any of the following factors affect access to the influenza vaccine?
(Put an X where you consider the most suitable)

  Major barrier Minor barrier Could be a barrier It's not a barrier I don't know
Cost of the influenza vaccine
Availability of the influenza vaccine
Patients’ beliefs about the benefits influenza vaccine
Belief of the Physician about risk-benefits of influenza vaccine
Physicians’ fear of side effects of influenza vaccine
Patients’ fears of side effects of influenza vaccine

Question Title

* Do you have any checklist or other kind of reminder to prescribe high risk patients the influenza vaccine?

Question Title

* Have you ever attended courses, brief meetings or classes on the relationship between influenza infection and its cardiovascular effects?

Question Title

* On a scale from 1 to 5, how relevant do you consider this topic is in your daily practice?
(1 being "not at all relevant" and 5 being "very relevant")

1 5
Clear
i We adjusted the number you entered based on the slider’s scale.
Page1 / 1
 
 100% of survey complete.
( Privacy & Cookie Notice

T